PARMA, Italy, Feb. 3, 2025 /PRNewswire/ -- Chiesi Global Rare Diseases ... Long-term motor function and quality of life outcomes in patients with alpha-mannosidosis: Data from two velmanase ...

In a high-water mark ... on improving patient quality of life in asthma and COPD and will present during a poster session findings from the TANGO trial, where Chiesi is looking at patient ...

Furthermore, Chiesi has, as a rule, the attraction of talent: talent acquisition is what results in high-quality businesses, and the new Biotech Centre of Excellence will do precisely that.

Protalix has partnered with Chiesi Farmaceutici S.p.A. for the global development and commercialization of Elfabrio. Protalix's development pipeline consists of proprietary versions of recombinant ...

Chiesi UK & Ireland has published new research revealing significant gaps in the understanding and practice of inhaler use among UK asthma patients. The study published in the BMJ Open Respiratory ...

"DeepSeek has primarily become popular due to the high-quality content that can be generated using the company's large ...

Tokyo-based startup ArkEdge Space claims it has snapped what is “probably” the highest quality images of Earth taken by a ...

Rare diseases present unique challenges that demand our immediate atteArticlention and action — not only because of the ...

Since opening its doors in 1981, Nohra Haime Gallery has been recognized for its consistent representation of International, Latin American, sculpture and women artists, often exhibiting work that ...

NEW YORK, Jan. 20, 2025 /PRNewswire/ -- The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024 to 2028, according to Technavio. The market is estimated to ...